Axiom University
Fusion eClinical Suite – Training Material
Fusion eClinical Suite
Data Driven Studies: Fusion is Axiom’s proprietary, easy-to-use and cost-effective eClinical solution that is focused on small to medium sized device, pharma, and biotech companies.
Over 15 fully integrated modules that connect seamlessly in one unified platform – accessible with a single sign-on.
Training Material
Axiom offers the following training material(s) available for the REGENXBIO – ASCENT study:
Pioneering a new field of discovery
REGENXBIO is seeking to improve lives through the curative potential of gene therapy. Our NAV® Technology Platform has ushered in a new era of gene therapy innovation.
ASCENT™ Study
ASCENT is a multi-center, randomized, active-controlled trial to evaluate the efficacy and safety of a single administration of RGX-314 versus standard of care in patients with wet AMD.